These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25470916)

  • 1. [Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease].
    Mukhin VN
    Ross Fiziol Zh Im I M Sechenova; 2013 Jul; 99(7):793-804. PubMed ID: 25470916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of the basal forebrain cholinergic dysfunction in pathogenesis of declarative memory disorder in Alzheimer's disease].
    Mukhin VN
    Ross Fiziol Zh Im I M Sechenova; 2013 Jun; 99(6):674-81. PubMed ID: 24459876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.
    Schliebs R
    Neurochem Res; 2005; 30(6-7):895-908. PubMed ID: 16187224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
    Auld DS; Kornecook TJ; Bastianetto S; Quirion R
    Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.
    Nyakas C; Granic I; Halmy LG; Banerjee P; Luiten PG
    Behav Brain Res; 2011 Aug; 221(2):594-603. PubMed ID: 20553766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
    Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research.
    Hampel H; Mesulam MM; Cuello AC; Khachaturian AS; Vergallo A; Farlow MR; Snyder PJ; Giacobini E; Khachaturian ZS
    J Prev Alzheimers Dis; 2019; 6(1):2-15. PubMed ID: 30569080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.
    Chan-Palay V
    J Comp Neurol; 1988 Jul; 273(4):543-57. PubMed ID: 2463283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [beta-Amyloid, cholinergic neurons and Alzheimer's disease].
    Kasparová J; Dolezal V
    Cesk Fysiol; 2002 May; 51(2):82-94. PubMed ID: 12053492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of estrogen on survival of basal forebrain cholinergic neurons: promoting amelioration.
    Abrahám IM; Koszegi Z; Tolod-Kemp E; Szego EM
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S104-12. PubMed ID: 19560872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
    Schliebs R; Arendt T
    J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of the brain cholinergic neurons in neurodegenerative diseases.
    Pepeu G; Grazia Giovannini M
    Brain Res; 2017 Sep; 1670():173-184. PubMed ID: 28652219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?
    Härtig W; Bauer A; Brauer K; Grosche J; Hortobágyi T; Penke B; Schliebs R; Harkany T
    Rev Neurosci; 2002; 13(2):95-165. PubMed ID: 12160262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegeneration and dementia. Alzheimer's disease as a model.
    Beyreuther K; Masters CL
    Arzneimittelforschung; 1995 Mar; 45(3A):347-50. PubMed ID: 7763324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early stages of pathogenesis in memory impairment during normal senescence and Alzheimer's disease.
    Daulatzai MA
    J Alzheimers Dis; 2010; 20(2):355-67. PubMed ID: 20164576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.